Human MCP-1 Platinum ELISA

Description: The human MCP-1 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human MCP-1. The human MCP-1 ELISA is for in vitro diagnostic use. Not for use in therapeutic procedures.

MCP-1was characterized as a monocyte-specific chemoattractant that was later shown to attract also T lymphocytes and NK cells.
The human mature MCP-1 protein consists of 76 amino acids, derived by cleavage of a hydrophobic signal peptide from the 99 aa precursor protein. MCP-1 is mainly expressed by macrophages in response to a wide range of cytokines such as IL-6, TNF-alpha and IL-1beta, but can, upon stimulation, also be produced by a variety of cells and tissues, such as fibroblasts, endothelial cells or certain tumor cells.
Because of its target cell specificity, MCP-1 was postulated to play a pathogenic role in a variety of diseases characterized by mononuclear cell infiltration, including atherosclerosis, rheumatoid arthritis and allergic responses. In basophils, MCP-1 is highly effective as a stimulus of histamine release but has only weak chemotactic activity. Additionally it has been shown to chemoattract CD4+ and CD8+ T lymphocytes, and expression of the MCP-1 chemokine may affect HIV infection via signaling through the CCR2 receptor.

Citations: Boucharaba,Ahmed; Serre,Claire Marie; Guglielmi,Julien; Bordet,Jean Claude; Clezardin,Philippe; Peyruchaud,Olivier. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proceedings of the National Academy of Sciences U.S.A. 2006;103:9643-9648. (Link)

Karth,Georg Delle; Buberl,Anton; Nikfardjam,Mariam; Meyer,Brigitte; Wollenek,Gregor; Grimm,Michael; Lassnigg,Andrea; Brannath,Werner; Hiesmayr,Michael; Heinz,Gottfried. Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions: [Role de l'amiodarone sur la reaction inflammatoire systemique provoquee par la chirurgie cardiaque : actions pro-inflammatoires]. Canadian Journal of Anesthesia 2007;54:262-268. (Link)

Schernthaner,G.H.; Kopp,H.P.; Krzyzanowska,K.; Kriwanek,S.; Koppensteiner,R.; Schernthaner,G.. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. European Journal of Clinical Investigation 2006;36:395-401. (Link)

Rottner,Mathilde; Kunzelmann,Corinne; Mergey,Martine; Freyssinet,Jean Marie; Martinez,Maria Carmen. Exaggerated apoptosis and NF-{kappa}B activation in pancreatic and tracheal cystic fibrosis cells. FASEB Journal 2007;fj(Link)

Roth,Georg A.; Ankersmit,Hendrik J.; Brown,Vinette B.; Papapanou,Panos N.; Schmidt,Ann Marie; Lalla,Evanthia. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiology Letters 2007;272:106-113. (Link)

He,Yin Yan; Du,Mei Rong; Guo,Pei Fen; He,Xiao Ju; Zhou,Wen hui; Zhu,Xiao Yong; Li,Da Jin. Regulation of C-C motif chemokine ligand 2 and its receptor in human decidual stromal cells by pregnancy-associated hormones in early gestation. Human Reproduction 2007;22:2733-2742. (Link)

Tang,Sydney C.W.; Leung,Joseph C.K.; Chan,Loretta Y.Y.; Tsang,Anita W.L.; Lai,Kar Neng. Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist. Journal of the American Society of Nephrology 2006;17:1633-1643. (Link)

VANCOVA,I.; SLOVAK,M.; HAJNICKA,V.; LABUDA,M.; SIMO,L.; PETERKOVA,K.; HAILS,R.S.; NUTTALL,P.A.. Differential anti-chemokine activity of Amblyomma variegatum adult ticks during blood-feeding. Parasite Immunology 2007;29:169-177. (Link)

Cerri,Chiara; Chimenti,Daniele; Conti,Ilaria; Neri,Tommaso; Paggiaro,Pierluigi; Celi,Alessandro. Monocyte/Macrophage-Derived Microparticles Up-Regulate Inflammatory Mediator Synthesis by Human Airway Epithelial Cells. The Journal of Immunology 2006;177:1975-1980. (Link)

Steiner,Sabine; Speidl,Walter S.; Pleiner,Johannes; Seidinger,Daniela; Zorn,Gerlinde; Kaun,Christoph; Wojta,Johann; Huber,Kurt; Minar,Erich; Wolzt,Michael; Kopp,Christoph W.. Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo. Circulation 2005;111:1841-1846. (Link)

Lehle,Karla; Kunz-Schughart,Leoni A.; Kuhn,Peter; Schreml,Stephan; Birnbaum,Dietrich E.; Preuner,Juergen G.. Validity of a patient-derived system of tissue-specific human endothelial cells - Interleukin-6 as a surrogate marker in the coronary system. Heart and Circulatory Physiology 2007;293:1721-1728. (Link)

Staiger,H.; Machicao,F.; Machann,J.; Schick,F.; Kuulasmaa,T.; Laakso,M.; Fritsche,A.; Stefan,N.; Haring,H.U.. Genetic variation within the APPL locus is not associated with metabolic or inflammatory traits in a healthy White population. Diabetic Medicine 2007;24:817-822. (Link)

Schernthaner,G.H.; Plank,C.; Minar,E.; Bieglmayer,C.; Koppensteiner,R.; Schernthaner,G.. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. European Journal of Clinical Investigation 2006;36:333-339. (Link)

References: Carr,M.W.; Roth,S.J.; Luther,E.; Rose,S.S.; Springer,T.A.. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc.Natl.Acad.Sci.U.S.A 1994;91:3652-3656. (Link)

Kuna,P.; Reddigari,S.R.; Rucinski,D.; Oppenheim,J.J.; Kaplan,A.P.. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J.Exp.Med. 1992;175:489-493. (Link)

Shyy,Y.J.; Li,Y.S.; Kolattukudy,P.E.. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem.Biophys.Res.Commun. 1990;169:346-351. (Link)

Yoshimura,T.; Yuhki,N.; Moore,S.K.; Appella,E.; Lerman,M.I.; Leonard,E.J.. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989;244:487-493. (Link)

Namiki,M.; Kawashima,S.; Yamashita,T.; Ozaki,M.; Hirase,T.; Ishida,T.; Inoue,N.; Hirata,K.; Matsukawa,A.; Morishita,R.; Kaneda,Y.; Yokoyama,M.. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler.Thromb.Vasc.Biol. 2002;22:115-120. (Link)

Edwards,J.A.; Denis,F.; Talbot,P.J.. Activation of glial cells by human coronavirus OC43 infection 34. J.Neuroimmunol. 2000;108:73-81. (Link)

Tarzami,S.T.; Cheng,R.; Miao,W.; Kitsis,R.N.; Berman,J.W.. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death 119. J.Mol.Cell Cardiol. 2002;34:209-221. (Link)

Mahad,D.J.; Howell,S.J.; Woodroofe,M.N.. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J.Neurol.Neurosurg.Psychiatry 2002;72:498-502. (Link)

McManus,C.; Berman,J.W.; Brett,F.M.; Staunton,H.; Farrell,M.; Brosnan,C.F.. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J.Neuroimmunol. 1998;86:20-29. (Link)

Grammas,P.; Ovase,R.. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol.Aging 2001;22:837-842. (Link)

Mateo,L.; La,Linn M.; McColl,S.R.; Cross,S.; Gardner,J.; Suhrbier,A.. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8 86. Intervirology 2000;43:55-60. (Link)

Graves,D.T.; Jiang,Y.; Valente,A.J.. The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts. Front Biosci. 1999;4:D571-D580. (Link)

Baggiolini,M.; Dewald,B.; Moser,B.. Human chemokines: an update. Annu.Rev.Immunol. 1997;15:675-705. (Link)

Proost,P.; Wuyts,A.; Van,Damme J.. The role of chemokines in inflammation. Int.J.Clin.Lab Res. 1996;26:211-223. (Link)

Taub,D.D.; Proost,P.; Murphy,W.J.; Anver,M.; Longo,D.L.; Van,Damme J.; Oppenheim,J.J.. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J.Clin.Invest 1995;95:1370-1376. (Link)